Pharmaceutical Microbiology Testing
Nova's Current Good Laboratory Practices (cGLP) compliance program can have a significant impact on cost-effective pharmaceutical drug development and production and provides all personnel with a qualified approach to understanding pharmaceutical microbiological testing.
Nova's capabilities include:
- Sterility Testing USP <71>
- Bacterial Endotoxin Testing (Pyrogen Testing, LAL Testing) USP <85> Endotoxin Methods Provided: Gel Clot, Turbidimetric, and Kinetic Chromogenic
- Bioburden Testing ISO 11737
- Bacteriostasis/Fungistasis USP <71>, ISO 11737
- Microbial Limits USP <61>, <62>
- Minimal Inhibitory Concentration (MIC)